Back to today’s briefing

Story perspectives

Illumina Sues Element Biosciences Over Patent Infringement

5/20/2025

34 4

Summary

Story summary

Illumina has launched a lawsuit against Element Biosciences, accusing it of infringing five patents tied to genetic sequencing technologies. Illumina argues that Element is reaping profits from its innovations without fair compensation. As Element gears up for a courtroom battle, the case underscores its swift rise and fierce competition in the evolving market of advanced sequencing systems.

1 of 1

Story summary

Illumina has launched a lawsuit against Element Biosciences, accusing it of infringing five patents tied to genetic sequencing technologies. Illumina argues that Element is reaping profits from its innovations without fair compensation. As Element gears up for a courtroom battle, the case underscores its swift rise and fierce competition in the evolving market of advanced sequencing systems.